Last reviewed: June 17, 2026
Last updated: June 17, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Ozempic, has become one of the most studied weight loss medications in recent years. The landmark STEP trials documented an average weight loss of 15% of starting body weight over 68 weeks at the highest dose, compared to 2-3% with placebo. Understanding realistic timelines and expected outcomes helps patients set appropriate goals and stay motivated through their weight loss journey.
Average Weekly Weight Loss on Semaglutide
Most patients report losing between 1 and 2 pounds per week when taking semaglutide at therapeutic doses. This rate typically stabilizes after the first month and becomes more consistent as the body adjusts to the medication. Individual results depend heavily on starting weight, adherence to dose escalation, diet quality, and physical activity levels.
The STEP 1 trial, which enrolled over 1,600 adults with obesity, showed participants lost an average of 15.3 kilograms (about 34 pounds) over 68 weeks on the highest dose. Placebo groups lost only 2.6 kilograms during the same period. This demonstrates that semaglutide's effect on weight is significantly greater than diet and exercise alone for most patients.
Monthly Weight Loss Timeline: What to Expect
Month one typically produces modest results, as patients start at low doses (0.25 mg) to minimize side effects. Most people lose 2-4 pounds in the first four weeks, with appetite suppression being the primary mechanism. This initial phase helps the body adapt to the medication's effects on hunger signals and satiety.
Months two through four show accelerated weight loss as doses increase to 0.5 mg and beyond. Patients commonly report losing 4-8 pounds per month during this window, as appetite suppression deepens and metabolic effects become more pronounced. By month six, when most patients reach their target maintenance dose, weekly loss tends to plateau at 1-2 pounds per week. This slower pace after the initial rapid phase is normal and sustainable.
Factors That Influence Your Weight Loss Rate
Starting body weight significantly affects percentage-based weight loss. A person weighing 250 pounds losing 50 pounds represents a 20% reduction, while someone weighing 180 pounds losing the same amount represents a 28% reduction. Additionally, individuals with higher starting weights often experience faster initial weight loss due to larger caloric deficits from reduced food intake.
Genetic predispositions play a measurable role in semaglutide response. PlexusDx's Precision Peptide Genetic Test examines variants in the GLP1R gene (rs6923761) and other peptide-pathway markers that influence how your body responds to GLP-1 agonists. Patients with favorable genetic variants at these loci typically achieve weight loss results at the faster end of the spectrum, while others may progress at a steadier pace.
Lifestyle factors including sleep quality, stress management, nutritional choices, and exercise consistency all modulate weight loss outcomes. Patients who maintain a protein-rich diet, stay hydrated, and engage in regular movement typically lose weight faster than those who rely solely on appetite suppression. Conversely, chronic sleep deprivation and high stress can blunt weight loss velocity by 20-30%.
PlexusDx Compounded Semaglutide vs. Brand-Name Ozempic
PlexusDx offers compounded semaglutide injection from licensed 503A compounding pharmacies, delivering identical active ingredient to brand-name Ozempic at a significantly lower cost. Compounded semaglutide starts at $149 per month, regardless of dose, following the principle that your dose may need to go up but your price won't. Clinical efficacy and weight loss rates are equivalent between compounded and brand formulations when manufactured to pharmaceutical standards.
The key difference is accessibility and affordability. PlexusDx serves all 50 states without requiring insurance, membership fees, or prior authorization delays. Treatment is HSA and FSA eligible, making it financially feasible for patients who would otherwise forgo semaglutide therapy. Faster access to treatment means patients begin losing weight sooner, often completing their dose titration schedule weeks ahead of those navigating insurance approval processes.
For patients interested in personalized dosing strategy, PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after the first month). This test examines your genetic response patterns to GLP-1 therapy and maps 14 metabolic pathways across 49 peptides, providing insights that help optimize your treatment plan for maximum weight loss and minimal side effects.
Realistic Weight Loss Goals and Maintenance
Setting a target of 10-15% body weight loss over six months is realistic and medically significant. This level of weight reduction produces measurable improvements in blood pressure, blood sugar control, inflammation markers, and cardiovascular risk factors. Most patients find this range achievable with consistent medication use and modest lifestyle modifications.
Weight loss plateaus are normal and expected, typically occurring 12-18 months into treatment. At this point, some patients choose to continue semaglutide for weight maintenance while others may adjust their dose or explore complementary therapies. Maintaining lost weight requires ongoing medication, as studies show weight regain of 40-50% occurs within one year after stopping semaglutide. This is why PlexusDx emphasizes long-term, affordable treatment access rather than short-term interventions.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How much weight can I realistically lose in the first month on semaglutide?
Most patients lose 2-4 pounds in month one while starting at the lowest dose (0.25 mg). Rapid appetite suppression begins immediately, but dramatic weight loss occurs once doses increase to 0.5 mg and higher over subsequent weeks. Starting at a low dose is intentional—it allows your body to adapt and minimizes nausea.
What clinical trial data supports these weight loss rates?
The STEP 1 trial, published in NEJM, enrolled 1,961 patients and found that semaglutide at 2.4 mg weekly produced 15.3% average body weight loss over 68 weeks. The STEP 2 trial in patients with type 2 diabetes showed 9.6% weight loss. These results significantly exceed placebo and diet-only approaches.
Does PlexusDx compounded semaglutide produce the same weight loss as brand-name Ozempic?
Yes, compounded semaglutide from licensed 503A pharmacies contains identical active ingredient and achieves equivalent weight loss when manufactured to pharmaceutical standards. PlexusDx pricing starts at $149 per month with no flat per-compound pricing increases, meaning you gain access faster and more affordably than many brand-name routes.
What if I'm not losing weight as fast as expected?
Slower weight loss may reflect individual variation in GLP-1 receptor sensitivity, genetic factors influencing peptide pathway function, or lifestyle factors like sleep and stress. PlexusDx's Precision Peptide Genetic Test identifies your genetic response pattern to help optimize dosing and predict whether you may benefit from alternative or dual-compound therapies like GLP-Squared.
Can the Precision Peptide Genetic Test predict my weight loss rate?
The test examines key variants including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313, which influence how your body responds to appetite-suppressing peptides. Patients with favorable variants typically achieve weight loss at the faster end of the clinical spectrum, while the test helps identify those who may need dose optimization or combination therapy strategies.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can You Take Wegovy with Methotrexate? Navigating Weight Loss and Complex Health Needs
Ozempic and Alcohol: Understanding How to Drink Responsibly on Your Weight Loss Journey